Cite
Clinical impact of PET/MRI in oligometastatic colorectal cancer.
MLA
Furtado, Felipe S., et al. “Clinical Impact of PET/MRI in Oligometastatic Colorectal Cancer.” British Journal of Cancer, vol. 125, no. 6, Sept. 2021, pp. 975–82. EBSCOhost, https://doi.org/10.1038/s41416-021-01494-8.
APA
Furtado, F. S., Suarez-Weiss, K. E., Vangel, M., Clark, J. W., Cusack, J. C., Hong, T., Blaszkowsky, L., Wo, J., Striar, R., Umutlu, L., Daldrup-Link, H. E., Groshar, D., Rocco, R., Bordeianou, L., Anderson, M. A., Mojtahed, A., Qadan, M., Ferrone, C., & Catalano, O. A. (2021). Clinical impact of PET/MRI in oligometastatic colorectal cancer. British Journal of Cancer, 125(6), 975–982. https://doi.org/10.1038/s41416-021-01494-8
Chicago
Furtado, Felipe S, Krista E Suarez-Weiss, Mark Vangel, Jeffrey W Clark, James C Cusack, Theodore Hong, Lawrence Blaszkowsky, et al. 2021. “Clinical Impact of PET/MRI in Oligometastatic Colorectal Cancer.” British Journal of Cancer 125 (6): 975–82. doi:10.1038/s41416-021-01494-8.